Major Clinical Results
- Having attempted the medical treatment and hyperthermia therapy first in the world that uses lipiodol, which is I-131 radioisotope
- Publishing the hepatocellular carcinoma treatment and clinical result of using Holmium-166/chitosan complex (Milican) developed in Korea in 1998 on the Journal of American Association for Cancer Research (AARC), which is a prominent international science journal
- Providing optimal radiotherapy based on the intensity-modulated radiation therapy (IMRT) and tomotherapy
- Patent application for the early prediction model of hepatocellular carcinoma by building a database from the government-supported research subject for the early diagnosis of hepatocellular carcinoma by developing hepatocellular carcinoma biomarker and applying it clinically
- We are consistently carrying out various research projects while maintaining close relationship with foreign research institutes by entering agreements for cooperative researches with prominent research institutes such as the Kurume University Liver Cancer Center and have accumulated the diagnosis and treatment results of treating and diagnosing hepatocellular carcinoma that is the largest size of database in the world.